The general rise in the chance of uterine cancer with tamoxifen use is very low (below 1%), and it goes back to standard in a couple of years of stopping the drug. Development happening six or more months soon after initiating the very first endocrine therapy for metastatic sickness (either https://chancepvahl.blogolenta.com/28647698/not-known-facts-about-ro-5126766